Taking semaglutide once weekly may lower the chances of kidney disease, says study

FHS
May 28, 2024
10:12 am

The effects of semaglutide (administered once weekly) on the outcomes of kidney disease.

Pharmalittle: We’re reading about Biocon eyeing weight loss drugs, Sanofi layoffs, and more

Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating because the usual routine of online meetings,

April 8, 2024

Benefits of postpartum dietary intervention on weight management in obese women

Researchers explore the effects of a dietary intervention in postpartum women with higher body mass index.

October 2, 2023

Ex-Metacrine chief Preston Klassen recharges at microRNA biotech; Allogene begins search for a CFO

→ Preston Klassen has mapped out his next destination as president and R&D chief of microRNA developer Regulus Therapeutics. Klassen was the CEO of Metacrine,

June 17, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.